DE60233819D1 - Doppelester - Google Patents

Doppelester

Info

Publication number
DE60233819D1
DE60233819D1 DE60233819T DE60233819T DE60233819D1 DE 60233819 D1 DE60233819 D1 DE 60233819D1 DE 60233819 T DE60233819 T DE 60233819T DE 60233819 T DE60233819 T DE 60233819T DE 60233819 D1 DE60233819 D1 DE 60233819D1
Authority
DE
Germany
Prior art keywords
esters
doppelester
alkane
therapeutic
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233819T
Other languages
German (de)
English (en)
Inventor
Jo Klaveness
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Discovery Laboratory AS
Original Assignee
Drug Discovery Laboratory AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Discovery Laboratory AS filed Critical Drug Discovery Laboratory AS
Application granted granted Critical
Publication of DE60233819D1 publication Critical patent/DE60233819D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/50—Sebacic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44—Adipic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/48—Azelaic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Tires In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60233819T 2001-11-22 2002-11-22 Doppelester Expired - Lifetime DE60233819D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0128052.8A GB0128052D0 (en) 2001-11-22 2001-11-22 Compounds
PCT/GB2002/005305 WO2003045893A1 (en) 2001-11-22 2002-11-22 Double esters

Publications (1)

Publication Number Publication Date
DE60233819D1 true DE60233819D1 (de) 2009-11-05

Family

ID=9926289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233819T Expired - Lifetime DE60233819D1 (de) 2001-11-22 2002-11-22 Doppelester

Country Status (15)

Country Link
US (1) US7629383B2 (enExample)
EP (1) EP1448508B1 (enExample)
JP (1) JP4426298B2 (enExample)
KR (1) KR20040071138A (enExample)
CN (1) CN100516018C (enExample)
AT (1) ATE443695T1 (enExample)
AU (1) AU2002343086C1 (enExample)
CA (1) CA2467773C (enExample)
DE (1) DE60233819D1 (enExample)
GB (1) GB0128052D0 (enExample)
HU (1) HUP0402122A2 (enExample)
MX (1) MXPA04004763A (enExample)
NO (1) NO20042603L (enExample)
RU (1) RU2350599C2 (enExample)
WO (1) WO2003045893A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE102006004804A1 (de) * 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
GB8310080D0 (en) * 1983-04-14 1983-05-18 Interox Chemicals Ltd Bleach composition
DE3465334D1 (en) 1983-04-14 1987-09-17 Interox Chemicals Ltd Peroxygen compounds
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
LU86918A1 (fr) * 1987-06-12 1989-03-08 Oreal Nouveaux diesters de l'acide azelaique,leur procede de preparation,les compositions topiques les contenant et leur utilisation dans le traitement de l'acne
EP0577659B1 (en) 1991-03-28 1996-01-17 Nycomed Imaging As Cross-linking agent
CZ284844B6 (cs) 1992-03-06 1999-03-17 Nycomed Imaging A/S Kontrastní prostředek a způsob jeho výroby
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
JP4029440B2 (ja) 1997-07-09 2008-01-09 大日本インキ化学工業株式会社 側鎖型ラジカル重合性化合物及びそれを用いた液晶デバイス

Also Published As

Publication number Publication date
NO20042603L (no) 2004-06-21
RU2350599C2 (ru) 2009-03-27
AU2002343086B2 (en) 2008-01-03
CN100516018C (zh) 2009-07-22
JP2005510556A (ja) 2005-04-21
CA2467773C (en) 2011-08-16
MXPA04004763A (es) 2004-07-30
GB0128052D0 (en) 2002-01-16
AU2002343086C1 (en) 2008-06-26
CA2467773A1 (en) 2003-06-05
US20050203181A1 (en) 2005-09-15
WO2003045893A1 (en) 2003-06-05
HUP0402122A2 (hu) 2005-02-28
AU2002343086A1 (en) 2003-06-10
JP4426298B2 (ja) 2010-03-03
US7629383B2 (en) 2009-12-08
KR20040071138A (ko) 2004-08-11
EP1448508A1 (en) 2004-08-25
RU2004118713A (ru) 2005-03-27
ATE443695T1 (de) 2009-10-15
EP1448508B1 (en) 2009-09-23
CN1589254A (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
AU2002216897A1 (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
ATE443695T1 (de) Doppelester
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
WO2005034929A3 (en) Tissue remodeling and vascularization
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DE60003074D1 (de) Fusidinsäure-derivate
TW200514775A (en) Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
DE60226126D1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
ATE299704T1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803

8364 No opposition during term of opposition